Moment Of Truth In EU For Amarin’s ‘Multi-Billion-Dollar Opportunity’ Drug

 
• By Neena Brizmohun
  
Heart disease in a person with obesity, conceptual image. 3D illustration showing increased weight male with obese heart
Vascepa is designed to lower cardiovascular risk • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet